戻る Agenda
SESSION 3: REGULATORY INNOVATION AND CHALLENGES
Session Chair(s)
Trevor M. Jones, CBE
former Director General ABPI
King's College London, United Kingdom
The objective of this session is to share new paradigms in regulatory science and current developments. To facilitate registration of medicinal products & increase efficiency (through collaboration, work-sharing and implementation of global norms and standards).
Speaker(s)
WHO Perspective
Lembit Rago, DrMed, MD, PHD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General
Industry Perspective
Florence Roizard, PHARMD
MSD France, France
Vice President, Regulatory Affairs International
The Saudi Food and Drug Authority: An Evaluation of Registration Procedures & Good Review Practices in Saudi Arabia in Comparison with Australia, Canada & Singapore
Hajed M.H Hashan
Gulf Health Council, Saudi Arabia
Deputy of General Director
A Structured Approach to the Benefit-Risk Assessment of Medicines: Key to Improving Decision Making in Drug Development and the Regulatory Review in the Gulf Region
Stuart Russel Walker, PHD
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant